The China Securities Regulatory Commission (CSRC) has approved a plan to combine China Meheco Corporation (SHSE: 600056) with Henan Topfond Pharmaceutical Co., Ltd. (SHSE: 600253). After a year's of twists and turns, the two listed ...
Tags: Meheco, Topfond Pharm